| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Feb 25 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 58.95 | 3,562.341 | 210.00 k | 7,826.704 |
| 31 Dec 24 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 56.56 | 552.511 | 31.25 k | 4,220.713 |
| 6 Nov 24 | KLAC KLA | Common Stock | Grant | Acquire A | No | No | 0 | 350 | 0.00 | 975 |
| 30 Sep 24 | BMY Bristol-Myers Squibb | Deferred Share Units Common Stock, $0.10 par value | Grant | Acquire A | No | No | 51.74 | 603.981 | 31.25 k | 3,628.127 |
| 29 Jul 24 | BMY Bristol-Myers Squibb | Call Option (obligation to sell) Common Stock, $0.10 par value | Other | Dispose J | Yes | No | 46 | 5 | 230.00 | 0 |
